-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Overweight on Anterix, Raises Price Target to $67

Benzinga·02/13/2025 15:52:54
Listen to the news
JP Morgan analyst Jerome Darling maintains Anterix (NASDAQ:ATEX) with a Overweight and raises the price target from $61 to $67.